Brainstorm Cell Therapeutics, Inc (NASDAQ:BCLI) -13.11% Down Over The Last Seven Days. Can The Stock Hit Well Above -$0.1600?
In last trading session, Brainstorm Cell Therapeutics, Inc (NASDAQ:BCLI) saw 0.42 million shares changing hands with its beta currently measuring 0.21. Company’s recent per share